Seeking Alpha

Covidien (COV) announces it purchased privately-held Barrx Medical in a $325M deal expected to...

Covidien (COV) announces it purchased privately-held Barrx Medical in a $325M deal expected to close in Q1. The firm says the acquisition will help expand its ability to treat gastrointestinal diseases, such as Barrett’s esophagus.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs